Royal Bank Of Canada Castle Biosciences Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Castle Biosciences Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 11,251 shares of CSTL stock, worth $342,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,251

Previous 6,721 67.4%

Holding current value

$342,480

Previous $146,000 119.18%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $78,822 - $142,559	4,530 Added 67.4%	11,251 $320,000
Q2 2024 Aug 14, 2024	BUY	$18.84 - $24.94 $67,239 - $89,010	3,569 Added 113.23%	6,721 $146,000
Q1 2024 Nov 05, 2024	SELL	$18.06 - $25.3 $64,456 - $90,295	-3,569 Reduced 53.1%	3,152 $69,000
Q1 2024 May 15, 2024	SELL	$18.06 - $25.3 $120,767 - $169,181	-6,687 Reduced 67.96%	3,152 $69,000
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $65,582 - $120,673	5,380 Added 120.65%	9,839 $212,000
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $20,969 - $32,053	1,579 Added 54.83%	4,459 $75,000
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $9,677 - $21,580	830 Added 40.49%	2,880 $39,000
Q1 2023 May 15, 2023	SELL	$19.47 - $28.49 $42,386 - $62,022	-2,177 Reduced 51.5%	2,050 $46,000
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $20,249 - $33,600	1,120 Added 36.05%	4,227 $99,000
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $46,933 - $71,557	-2,085 Reduced 40.16%	3,107 $81,000
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $56,480 - $162,344	3,530 Added 212.39%	5,192 $114,000
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $110,854 - $157,007	-3,342 Reduced 66.79%	1,662 $75,000
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $77,221 - $133,605	1,977 Added 65.31%	5,004 $214,000
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $75,282 - $97,155	1,252 Added 70.54%	3,027 $202,000
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $88,874 - $136,284	1,775 New	1,775 $130,000

Others Institutions Holding CSTL

# of Institutions

202

Shares Held

26M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $800M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Castle Biosciences Inc Transaction History